Diabetes
Patients taking Avandia, an oral diabetes drug from GlaxoSmithKline, proved 43 percent more likely to have heart attacks in a recent study published in the New England Journal of Medicine. Higher death rates accompanied the greater heart attack rates, researcher Steven Nissen, chair of cardiology at the Cleveland Clinic reported, along with associate Kathy Wolski. |
|